Evidence map›Paper›PMID 33670786›Full record

ReviewInternational journal of molecular sciences2021

DING Proteins Extend to the Extremophilic World.

Elena Porzio, Maria Rosaria Faraone Mennella, Giuseppe Manco

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elena PorzioInstitute of Biochemistry and Cell Biology, CNR, Via P. Castellino 111, 80131 Naples, Italy.ORCID 0000-0001-8018-9752
Maria Rosaria Faraone MennellaDepartment of Biology, Polytechnic School of Basic Sciences, University of Naples "Federico II", 80126 Naples, Italy.ORCID 0000-0003-1947-4700
Giuseppe MancoInstitute of Biochemistry and Cell Biology, CNR, Via P. Castellino 111, 80131 Naples, Italy.ORCID 0000-0001-6191-3952

Funding

POR project "Prodotti Alimentari" 2014-2020 from Campania Region ; POC-SIABIO 2019-2021 project from the Italian Ministry of University and Research (MUR) POR03; POC01_00042
6 · The paper itself

Abstract

The DING proteins are ubiquitous in the three domains of life, from mesophiles to thermo- and hyperthermophiles. They belong to a family of more than sixty members and have a characteristic N-terminus, DINGGG, which is considered a "signature" of these proteins. Structurally, they share a highly conserved phosphate binding site, and a three dimensional organization resembling the "Venus Flytrap", both reminding the ones of PstS proteins. They have unusually high sequence conservation, even between distantly related species. Nevertheless despite that the genomes of most of these species have been sequenced, the DING gene has not been reported for all the relative characterized DING proteins. Identity of known DING proteins has been confirmed immunologically and, in some cases, by N-terminal sequence analysis. Only a few of the DING proteins have been purified and biochemically characterized. DING proteins are heterogeneous for their wide range of biological activities and some show different activities not always correlated with each other. Most of them have been originally identified for different biological properties, or rather for binding to phosphate and also to other ligands. Their involvement in pathologies is described. This review is an update of the most recent findings on old and new DING proteins.

Indexed as

Amino Acid SequenceArchaeaEukaryotaExtremophilesPhosphate-Binding ProteinsPhosphate-Binding ProteinsArchaeaDING proteineukaryotesextremophilesPARPSsophosphate-binding proteinsprokaryotes

Identifiers

PMID33670786
PMCPMC7922408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.